Ledger.Open graph →
SEC Form D · filed January 4, 2024

Biodexa Pharmaceuticals Plc

Offering
$6.8M
Sold
$6.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CARDIFF, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Dmitry Zamoryakhin · Cardiff, United KingdomExecSijmen De Vries · Cardiff, United KingdomDirectorStephen Stamp · Cardiff, United KingdomExec · DirectorStephen Parker · Cardiff, United KingdomDirectorSimon Turton · Cardiff, United KingdomDirectorSanjay D. Nath · Mumbai, Maharashtra, K7ExecAshish B. Fafadia · Mumbai, K7DirectorUmesh P. Salvi · Mumbai, Maharashtra, K7Exec · DirectorJayesh B. Pandit · Mumbai, Maharashtra, K7DirectorGreg Nobile · New York, NYDirectorKatherine Eade · Morrisville, NCExecShankar Ramaswamy · Morrisville, NCDirectorBritt Petty · Morrisville, NCDirectorRoger Jeffs · Morrisville, NCExec · DirectorMatt Murphy · Boerne, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗